Thubilux Pharma SpA has received a structured loan of US$2.7 million from a leading Italian bank
Tubilux Pharma SpA has successfully raised funds through a structured loan from Cassa Depositi e Prestiti SpA and Banca Intesa San Paolo SpA to support an investment plan for a new production facility which has all the FDA requirements to enter the USA market.
Tubilux Pharma is a leading, privately-held ophthalmic and pharmaceuticals company that develops and markets a range of proprietary, over-the-counter, and branded generic products, with distribution in approximately 30 countries. The firm's customers are large multinational pharmaceutical companies that outsource their production of ophthalmic products to specialized manufactures through medium-term supply contracts (3-5 years).
Oaklins' team in Italy advised Thubilux Pharma SpA in the structuring, negotiation and closing of a long-term debt financing from a leading Italian bank, backed by Cassa Depositi e Prestiti.
Talk to the deal team
Marie Gabriella Sestini
Ashtrom Group Ltd. has issued bonds to refinance the company
Ashtrom Group Ltd. has raised funds to refinance the company for further development.Learn more
Azrieli Group Ltd. has raised capital through a bond placement
Azrieli Group Ltd. has completed a fundraising to refinance and develop the company.Learn more
REIT 1 Ltd. has raised capital through a bond placement
REIT 1 Ltd. has completed a fundraising to refinance and develop the company.Learn more